According to analysis by @moderna_tx, 20 percent of participants in UK industry-sponsored clinical research were enrolled in a Moderna trial in 2023/2024.

“Excitingly, advances in gene editing are happening very rapidly. it seems likely that cheaper, safer and more effective forms of gene editing will emerge for sickle cell disease over the coming years,” commented Professor Rees of King’s College London.

"This year’s figures demonstrate that biotech is a vibrant growth sector of the UK economy with an exceptional ability to attract global investment," says @BIA_UK's CEO.

"With nearly two-thirds of all major #pharma company revenues set to come from dealmaking in the next five years, deals will remain at the centre of #lifesciences strategy," says @EYnews Global Life Sciences Deals Leader.

Oncology continues to be the dominant area in early-phase ATMP clinical trials for investigational therapies, the report data shows. #pharma #clinicaltrials

The new recommendations will support health technology assessment (HTA) and aid technology developers to provide data for evidence submissions.

The acquisition will include rights to a TKI molecule, which according to @GSK's CSO, has potential to help close a major gap in the current standard of care of gastrointestinal stromal tumours.

Gene editing technologies are expected to innovate #pharma personalised medicine in 2025, says @ClarivateHealth 's latest Drugs to Watch report. #drugdevelopment.

As part of the agreement, @bmsnews is responsible for development and commercialisation of the novel antibodies and related products. #biologics #EPRtalks

"Approval by the [European Commission] is significant because Elahere is the first new medication approved specifically for platinum-resistant ovarian cancer since 2014". #pharma #EPRTalks

"These reforms protect the safe development of pioneering new treatments," Dr June Raine, @MHRAgovuk Chief Executive stated. #EPRTalks.

“By combining our expertise in #clinicaltrials and #lifesciences with world-class researchers, we can accelerate the development of groundbreaking treatments that will benefit patients across [the UK and Switzerland]” says UK Health Minister. #EPRTalks

AD | Making spirits bright!. Save 25% and enjoy free gummi bears with our most popular nucleic purification kits. Whether you’re looking for #DNA, #RNA, or #plasmidpurification, clean-up for #NGS, gels, or PCR, we’ve got the perfect kit.

The new appointments by @Amgen and @pfizer will drive development of new medicines across numerous therapeutic areas such as rare disease and cancer. #EPRTalks.

Investment in @sanofi's Lyon Gerland site will aid internal bioproduction of a type 1 #diabetes drug, enabling market availability in 2027. #pharmaceuticalmanfacturing #EPRTalks.

As part of the acquisition, @BioNTech_Group will gain rights to a state-of-the-art biologics manufacturing facility. #biologics #EPRTalks.

🚨 Last Chance! 🚨. Join us this week for a webinar with Vivien Knospe from FUJIFILM WAKO Chemicals on the Monocyte Activation Test (MAT)!. 📅 Register now: #mat #monocyteactivationtest #webinar

A key benefit of the film bag “is its simplicity because no equipment for mechanical aeration is required”. #microbiology #EPRTalks

The drug candidate included in the @abbvie deal transports the antibody across the blood-brain barrier to enable degradation of amyloid beta plaque. #Alzheimers

Join Vivien Knospe from FUJIFILM WAKO Chemicals to discuss the Monocyte Activation Test (MAT)!. Learn about:.✅ MAT implementation in the EU.✅ Status in pharmacopoeias (USP, EP, JP, ChP).✅ Performing a MAT assay. 📅 Register now: